Author:
Noel Jason M.,Curtis Judy L.
Reference20 articles.
1. Altamura, A. C., Moliterno, D., Paletta, S., Maffini, M., Massimo, C. M., & Bareggi, S. (2013). Understanding the pharmacokinetics of anxiolytic drugs. Expert Opinion on Drug Metabolism & Toxicology, 9, 423–440.
https://doi.org/10.1517/17425255.2013.759209
.
2. American Psychiatric Association. (2004). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Arlington, VA: American Psychiatric Association. Available online at:
http://psychiatryonline.org/guidelines.aspx
.
3. American Psychiatric Association. (2009). Treatment of patients with panic disorder. Arlington, VA: American Psychiatric Association. Available online at:
http://psychiatryonline.org/guidelines.aspx
.
4. Baek, J. H., Nierenberg, A. A., & Kinrys, G. (2014). Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder. Australian and New Zealand Journal of Psychiatry, 48, 705–715.
https://doi.org/10.1177/0004867414539198
.
5. Bidzan, L., Mahableshwarkar, A. T., Jacobsen, P., Yan, M., & Sheehan, D. V. (2012). Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial. European Neuropsychopharmacology, 22, 847–857.
https://doi.org/10.1016/j.euroneuro.2012.07.012
.